← Scroll Down

News & Media

Diplomat to Release 2018 Financial Results, 2019 Guidance Feb. 25

FLINT, Mich. — Jan. 28, 2019 — Diplomat Pharmacy, Inc. (NYSE: DPLO), will report its fourth-quarter and year-end 2018 financial results — and provide 2019 guidance — after market close Monday, Feb. 25. A conference call and live webcast will follow at 5 p.m. ET.

Shareholders and other interested parties can listen to the conference call live by dialing 833.286.5805 (647.689.4450 for international callers). Participation code 2672528 will start working about 15 minutes before the call. A live webcast will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. An audio recording and related materials will be available online for approximately 90 days.

About Diplomat

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.

Investor Contact

Terri Anne Powers

Vice President, Investor Relations

312.889.5244 | tpowers@diplomat.is


Kali Lucas

Partner Marketing Supervisor

810.768.9580 | press@diplomat.is

Newsletter Sign Up

Receive the latest updates to your inbox.

All Press Releases

Learn more about
Diplomat Specialty.

Visit diplomatpharmacy.com